Stimulus specific changes of energy metabolism in hypertrophied heart

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 6, 2009, Pages 952-959

  Rimbaud, S ^a,b   Sanchez, H ^c   Garnier, A ^a,b   Fortin, D ^a,b   Bigard, X ^c   Veksler, V ^a,b   Ventura Clapier, R ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c CENTRE DE RECHERCHES   (France)

Author keywords

Exercise training; Fatty acid oxidation; Hormonal activation; Hypertension; Hypertrophy; Mitochondrial biogenesis; Mitochondrial respiration; Oxidative capacity; PGC 1 ; Pregnancy; Remodelling; Stress

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE I MUSCLE ISOFORM; FATTY ACID; MIDDLE CHAIN ACYL COENZYME A DEHYDROGENASE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING; HEART WORK; LIPID OXIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION;

ACYL-COA DEHYDROGENASE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CARNITINE O-PALMITOYLTRANSFERASE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FEMALE; GLUCOSE TRANSPORTER TYPE 4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; OXYGEN CONSUMPTION; POLYMERASE CHAIN REACTION; PPAR ALPHA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RATS;

RATTUS;

EID: 67349190616     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.01.013     Document Type: Article

References (46)

1. Weber K.T., Clark W.A., Janicki J.S., and Shroff S.G. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. J. Cardiovasc. Pharmacol. 10 (1987) S37-S50
2. Selvetella G., Hirsch E., Notte A., Tarone G., and Lembo G. Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc. Res. 63 (2004) 373-380
3. McMullen J.R., and Jennings G.L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin. Exp. Pharmacol. Physiol. 34 (2007) 255-262
4. Richey P.A., and Brown S.P. Pathological versus physiological left ventricular hypertrophy: a review. J. Sports Sci. 16 (1998) 129-141
5. Dorn G., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115 (2005) 527-537
6. Stuewe S.R., Gwirtz P.A., Agarwal N., and Mallet R.T. Exercise training enhances glycolytic and oxidative enzymes in canine ventricular myocardium. J. Mol. Cell. Cardiol. 32 (2000) 903-913
7. Coleman R., Weiss A., Finkelbrand S., and Silbermann M. Age and exercise-related changes in myocardial mitochondria in mice. Acta Histochem. 83 (1988) 81-90
8. Murakami T., Shimomura Y., Fujitsuka N., and Sugiyama S. Differential adaptation to endurance training between heart and gastrocnemius muscle mitochondria in rats. Biochem. Mol. Biol. Int. 36 (1995) 285-290
9. Kayar S.R., Conley K.E., Claassen H., and Hoppeler H. Capillarity and mitochondrial distribution in rat myocardium following exercise training. J. Exp. Biol. 120 (1986) 189-199
10. Ventura-Clapier R., Mettauer B., and Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc. Res. 73 (2007) 10-18
11. Barger P.M., and Kelly D.P. PPAR signaling in the control of cardiac energy metabolism. Trends. Cardiovasc. Med. 10 (2000) 238-245
12. Finck B.N., and Kelly D.P. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J. Mol. Cell. Cardiol. 34 (2002) 1249-1257
13. Degens H., de Brouwer K.F., Gilde A.J., Lindhout M., Willemsen P.H., Janssen B.J., et al. Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart. Basic Res. Cardiol. 101 (2006) 17-26
14. de Brouwer K.F., Degens H., Aartsen W.M., Lindhout M., Bitsch N.J., Gilde A.J., et al. Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice. J. Mol. Cell. Cardiol. 40 (2006) 838-845
15. Iemitsu M., Miyauchi T., Maeda S., Sakai S., Fujii N., Miyazaki H., et al. Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens. Res. 26 (2003) 829-837
16. Veksler V.I., Kuznetsov A.V., Sharov V.G., Kapelko V.I., and Saks V.A. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim. Biophys. Acta 892 (1987) 191-196
17. Kuznetsov A.V., Veksler V., Gellerich F.N., Saks V., Margreiter R., and Kunz W.S. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat. Protoc. 3 (2008) 965-976
18. Bahi L., Garnier A., Fortin D., Serrurier B., Veksler V., Bigard A.X., et al. Differential effects of thyroid hormones on energy metabolism of rat slow- and fast-twitch muscles. J. Cell. Physiol. 203 (2005) 589-598
19. Veksler V.I., Kuznetsov A.V., Anflous K., Mateo P., van Deursen J., Wieringa B., et al. Muscle creatine kinase-deficient mice. 2. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. J. Biol. Chem. 270 (1995) 19921-19929
20. De Sousa E., Veksler V., Minajeva A., Kaasik A., Mateo P., Mayoux E., et al. Subcellular creatine kinase alterations - implications in heart failure. Circ. Res. 85 (1999) 68-76
21. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., and Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551 (2003) 491-501
22. Eghbali M., Deva R., Alioua A., Minosyan T.Y., Ruan H., Wang Y., et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ. Res. 96 (2005) 1208-1216
23. Pluim B.M., Zwinderman A.H., vanderLaarse A., and vanderWall E.E. The athlete's heart - a meta-analysis of cardiac structure and function. Circulation 101 (2000) 336-344
24. Moore R.L. Cellular adaptations of the heart muscle to exercise training. Ann. Med. 30 (1998) 46-53
25. Hajri T., Ibrahimi A., Coburn C.T., Knapp Jr. F.F., Kurtz T., Pravenec M., et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J. Biol. Chem. 276 (2001) 23661-23666
26. Muders F., and Elsner D. Animal models of chronic heart failure. Pharmacol. Res. 41 (2000) 605-612
27. Jankowski M., Wang D., Mukaddam-Daher S., and Gutkowska J. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle. J. Endocrinol. 184 (2005) 209-217
28. Yang J., Rothermel B., Vega R.B., Frey N., McKinsey T.A., Olson E.N., et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. 87 (2000) E61-E68
29. Rothermel B.A., McKinsey T.A., Vega R.B., Nicol R.L., Mammen P., Yang J., et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3328-3333
30. Lemmens K., Segers V.F., Demolder M., Michiels M., Van Cauwelaert P., and De Keulenaer G.W. Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy. Eur. J. Heart. Fail. 9 (2007) 352-356
31. Wilkins B.J., Dai Y.S., Bueno O.F., Parsons S.A., Xu J., Plank D.M., et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94 (2004) 110-118
32. Eto Y., Yonekura K., Sonoda M., Arai N., Sata M., Sugiura S., et al. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 101 (2000) 2134-2137
33. Lehman J.J., Barger P.M., Kovacs A., Saffitz J.E., Medeiros D.M., and Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 (2000) 847-856
34. Terblanche S.E., Gohil K., Packer L., Henderson S., and Brooks G.A. The effects of endurance training and exhaustive exercise on mitochondrial enzymes in tissues of the rat (Rattus norvegicus). Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 128 (2001) 889-896
35. Siu P.M., Donley D.A., Bryner R.W., and Alway S.E. Citrate synthase expression and enzyme activity after endurance training in cardiac and skeletal muscles. J. Appl. Physiol. 94 (2003) 555-560
36. 2+-induced permeability transition pore opening in heart mitochondria. Am. J. Physiol. Heart. Circ. Physiol. 290 (2006) H1549-1557
37. Leary S.C., Michaud D., Lyons C.N., Hale T.M., Bushfield T.L., Adams M.A., and Moyes C.D. Bioenergetic remodeling of heart during treatment of spontaneously hypertensive rats with enalapril. Am. J. Physiol. Heart. Circ. Physiol. 283 (2002) H540-H548
38. Marcil M., Ascah A., Matas J., Belanger S., Deschepper C.F., and Burelle Y. Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J. Mol. Cell. Cardiol. 41 (2006) 998-1009
39. Ponsot E., Zoll J., N'Guessan B., Ribera F., Lampert E., Richard R., et al. Quantitative and qualitative mitochondrial adaptations of substrates utilizations in rat cardiac and skeletal muscles. J. Cell. Physiol. 203 (2005) 479-486
40. Labarthe F., Khairallah M., Bouchard B., Stanley W.C., and Des Rosiers C. Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am. J. Physiol. Heart. Circ. Physiol. 288 (2005) H1425-H1436
41. Jin X., Xia L., Wang L.S., Shi J.Z., Zheng Y., Chen W.L., et al. Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics 6 (2006) 1948-1956
42. Stavinoha M.A., Rayspellicy J.W., Hart-Sailors M.L., Mersmann H.J., Bray M.S., and Young M.E. Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E878-E887
43. Burelle Y., Wambolt R.B., Grist M., Parsons H.L., Chow J.C., Antler C., et al. Regular exercise is associated with a protective metabolic phenotype in the rat heart. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) H1055-H1063
44. Burkart E.M., Sambandam N., Han X., Gross R.W., Courtois M., Gierasch C.M., et al. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J. Clin. Invest. 117 (2007) 3930-3939
45. Kohara K., Brosnihan K.B., and Ferrario C.M. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides 14 (1993) 883-891
46. Neri Serneri G.G., Boddi M., Modesti P.A., Cecioni I., Coppo M., Padeletti L., et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89 (2001) 977-982